tiprankstipranks
Oryzon Genomics Finalizes Capital Increase
Company Announcements

Oryzon Genomics Finalizes Capital Increase

Oryzon Genomics SA (ES:ORY) has released an update.

Oryzon Genomics S.A. has announced the registration of the deed of execution for its capital increase via convertible bonds in the Commercial Registry of Madrid.

For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistORN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks Spain Auto-Generated NewsdeskOryzon Genomics Bonds Converted to Shares
GlobeNewswireORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!